Breakthrough ALS Drug Tofersen Launches in China, Offering New Hope
Tofersen, a gene-targeted therapy for ALS caused by SOD1 mutations, is now available in China, offering hope for slowing disease progression.
GeneTherapy
Read More
PROTEUS Platform Revolutionizes Protein Design for Medical Breakthroughs
Australian scientists unveil PROTEUS, a protein engineering platform enabling breakthroughs in gene therapy & cancer research using mammalian cells.
China Approves First Gene Therapy for Hemophilia B in Major Medical Leap
China approves its first gene therapy for hemophilia B, BBM-H901, offering a potential long-term treatment for patients and advancing genomic medicine in Asia.